US Biologic joins the Securing America’s Medicines and Supply Coalition
“US Biologic envisions a world where everyone has equitable access to lifesaving technologies,” stated Mason Kauffman, CEO of US Biologic. “Our mission is to reduce disease through predictive analytics and orally delivered vaccines and therapeutics delivered to the home. The SAMS Coalition will help impact policy to rebuild American infrastructure and strategic product stockpiles, and US Biologic proudly supports efforts to strengthen our responses to future pandemic threats.”